Skip to content
PeptideTech
Cart

Home / Research library / PT-141

Peptides

PT-141: molecular data, studies & sources

PT-141 is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF)
C50H68N14O10
Molecular weight (MW)
1025.2 g/mol
PubChem compound ID
9941379
Record title
Bremelanotide

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 9941379 · retrieved 2026-09-21

PubChem 2D molecular structure for PT-141, CID 9941379
2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.
Chemical identifiers and source data
IUPAC name
(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid
InChIKey
FFHBJDQSGDNCIV-MFVUMRCOSA-N
SMILES
CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C
Machine-readable PubChem source

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

  1. Human study · PubMed trial index

    Safety Profile of Bremelanotide Across the Clinical Development Program.

    Clayton AH, Kingsberg SA, Portman D et al. · Journal of women's health (2002) · 2022

    PMID 35147466 · DOI: 10.1089/jwh.2021.0191

  2. Human study · PubMed trial index

    Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

    Kingsberg SA, Clayton AH, Portman D et al. · Obstetrics and gynecology · 2019

    PMID 31599840 · DOI: 10.1097/AOG.0000000000003500

  3. Human study · PubMed trial index

    Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.

    Simon JA, Kingsberg SA, Portman D et al. · Journal of women's health (2002) · 2022

    PMID 35230162 · DOI: 10.1089/jwh.2021.0225

  4. Human study · PubMed trial index

    Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.

    Safarinejad MR, Hosseini SY · The Journal of urology · 2008

    PMID 18206919 · DOI: 10.1016/j.juro.2007.10.063

  5. Human study · PubMed trial index

    Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.

    Althof S, Derogatis LR, Greenberg S et al. · The journal of sexual medicine · 2019

    PMID 31277966 · DOI: 10.1016/j.jsxm.2019.05.012

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

  1. Review · secondary evidence

    Bremelanotide: First Approval.

    Dhillon S, Keam SJ · Drugs · 2019

    PMID 31429064 · DOI: 10.1007/s40265-019-01187-w

PT-141 supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

Compare all PT-141 sizes, forms and supplier prices →

SupplierRecorded packagesExample source listing
Blank PeptidesUSD10mg Vial1 recorded offers10mg Vial · $55.00Checked Sep 21, 2026Supplier listing
American PeptidesUSD10mg Vial1 recorded offers10mg Vial · $60.00Checked Sep 21, 2026Supplier listing
Modified AminosUSD10mg Vial · 10mg Spray2 recorded offers10mg Vial · $29.99Checked Sep 16, 2026Supplier listing
Amino ClubUSD10mg Vial · 15mg Spray2 recorded offers10mg Vial · $29.99Checked Sep 16, 2026Supplier listing
Nova Peptide SupplyUSD10mg Vial1 recorded offers10mg Vial · $39.99Checked Sep 16, 2026Supplier listing
Amino USAUSD10mg Vial1 recorded offers10mg Vial · $40.50Checked Sep 16, 2026Supplier listing
Cenexa LabsUSD10mg Vial · 10mg Spray2 recorded offers10mg Vial · $44.99Checked Sep 16, 2026Supplier listing
US Peptide LabsUSD10mg Vial · 10mg Oral spray · 10mg Spray3 recorded offers10mg Vial · $55.00Checked Sep 16, 2026Supplier listing
Direct PeptidesUSD10mg Vial1 recorded offers10mg Vial · $89.00Checked Sep 16, 2026Supplier listing
Particle PeptidesEUR10mg Vial1 recorded offers10mg Vial · €49.99Checked Sep 16, 2026Supplier listing
Nuvion PeptidesCAD10mg Vial1 recorded offers10mg Vial · CA$54.99Checked Sep 21, 2026Supplier listing
PhaseOneAUD10mg Vial1 recorded offers10mg Vial · A$61.99Checked Sep 21, 2026Supplier listing
BioStacksCAD10mg Vial1 recorded offers10mg Vial · CA$90.00Checked Sep 21, 2026Supplier listing

Reference sources & further reading

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Search for additional research

These links run searches; their results have not been individually reviewed and can include unrelated compounds.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

Related research profiles